CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-24 | Giltner Richard Director | Exercise or conversion · Stock Option | −5,000 | 0 | ||
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −506 | $275.98 | $140K | 47,275 |
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,100 | $276.95 | $305K | 46,175 |
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,837 | $278.41 | $511K | 44,338 |
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,425 | $279.51 | $398K | 42,913 |
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,375 | $280.70 | $386K | 41,538 |
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −4,557 | $281.56 | $1.3M | 36,981 |
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $282.27 | $56K | 36,781 |
| 2025-06-12 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 132,000 | ||
| 2025-06-09 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion 10b5-1 | +12,000 | $117.76 | $1.4M | 20,118 |
| 2025-06-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,595 | $325.44 | $1.2M | 16,523 |
| 2025-06-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −305 | $326.56 | $100K | 16,218 |
| 2025-06-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −100 | $328.28 | $33K | 16,118 |
| 2025-06-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −7,700 | $325.20 | $2.5M | 8,418 |
| 2025-06-09 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −300 | $326.81 | $98K | 8,118 |
| 2025-06-09 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Option 10b5-1 | −12,000 | 87,500 | ||
| 2025-06-02 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion 10b5-1 | +12,000 | $117.76 | $1.4M | 20,118 |
| 2025-06-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,603 | $325.54 | $847K | 17,515 |
| 2025-06-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,397 | $326.34 | $456K | 16,118 |
Page 210 of 214 · 4,273 trades